☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Type 1 Plexiform Neurofibromas
AstraZeneca and MSD's Koselugo (selumetinib) Receives the US FDA's Approval as the First Therapy for Pediatric Patients with Neuro...
April 13, 2020
Load more...
Back to Home